UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005572 |
|---|---|
| Receipt number | R000006593 |
| Scientific Title | A phase II study of Perioperative FOLFOX4 plus Bevacizumab for initially unresectable Advanced Colorectal Cancer. |
| Date of disclosure of the study information | 2011/05/09 |
| Last modified on | 2016/02/16 11:03:19 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/05/09 00:56:35 | ||
| 2 | Update | 2012/05/26 12:14:42 | Recruitment status |
|
| 3 | Update | 2012/11/09 17:53:09 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2014/11/09 13:58:37 | Key exclusion criteria |
|
| 5 | Update | 2014/11/09 13:59:44 | Email |
|
| 6 | Update | 2014/11/20 16:50:17 | Interventions/Control_1 Interventions/Control_1 |
|
| 7 | Update | 2016/02/16 11:03:19 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |
